Living with depression can be hard enough without the added burden of sexual dysfunction. Many people who do not respond well to standard antidepressants find that their sex lives suffer as a side effect of their medication. This creates a difficult choice between managing mood and maintaining intimacy.
A Phase 3 clinical trial looked at 480 adults with Major Depressive Disorder who had not seen enough improvement from one or two previous antidepressant treatments. Researchers added lumateperone, a medication taken at 42 mg daily, to their existing treatment plans. They compared this to a placebo added to the same antidepressant therapy.
The results showed that patients taking lumateperone saw significant improvements in their sexual functioning scores after six weeks. These improvements were especially notable in women and in patients who started the study with existing sexual dysfunction. While the study is still early in its data reporting, the results suggest lumateperone could be a helpful addition for those struggling with these specific side effects.
